GGrantIndex
← Leaderboards

Miriam B. Vos

Emory University

$5,544,207
Attributed
$7,220,648
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,220,648 · 10

By mechanism

R01$3,745,880 · 2
K23$871,030 · 1
U2C$785,026 · 1
R61$644,415 · 1
R21$429,000 · 1
P30$318,565 · 1

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Child

Research focus

ChildAdultAffectLiver DiseasesResponseDietUnited StatesInflammationObesityResearch PersonnelFutureLipidsInsulin ResistanceSugarChildhoodFatty LiverPreventionLiverRandomizedDyslipidemiasHepaticOverweightInnovationMission

Grant awards (26)

A Sequential Multiple Assignment Randomized Trial of Diet Treatments for Hepatic Steatosis and Cardiometabolic Risk in Adolescents$644,415
R61 · FY2025 · HL · contact PI
Patient-Oriented Research for Cardiometabolic Health in Children$127,645
K24 · FY2025 · HL · contact PI
Prevention of Pediatric NAFLD in Hispanic Children$556,199
R01 · FY2024 · NR · contact PI
Patient-Oriented Research for Cardiometabolic Health in Children$127,645
K24 · FY2024 · HL · contact PI
Prevention of Pediatric NAFLD in Hispanic Children$576,074
R01 · FY2023 · NR · contact PI
Prevention of Pediatric NAFLD in Hispanic Children$585,432
R01 · FY2022 · NR · contact PI
Sibling Assessment in Prevention of Pediatric NAFLD in Hispanic Children$370,104
R01 · FY2022 · NR · contact PI
Biomarker Discovery for Nonalcoholic Fatty Liver Disease in Children$341,632
R01 · FY2022 · DK · contact PI
Lifestyle & Behaviors Core, Vos$109,744
P30 · FY2022 · DK · contact PI
Prevention of Pediatric NAFLD in Hispanic Children$620,659
R01 · FY2021 · NR · contact PI
Biomarker Discovery for Nonalcoholic Fatty Liver Disease in Children$341,528
R01 · FY2021 · DK · contact PI
Lifestyle & Behaviors Core, Vos$109,719
P30 · FY2021 · DK · contact PI
Biomarker Discovery for Nonalcoholic Fatty Liver Disease in Children$354,252
R01 · FY2020 · DK · contact PI
Lifestyle & Behaviors Core, Vos$99,102
P30 · FY2020 · DK · contact PI
Anti-LPS antibody for Pediatric Nonalcoholic Fatty Liver Disease$195,000
R21 · FY2017 · HD · contact PI
Anti-LPS antibody for Pediatric Nonalcoholic Fatty Liver Disease$234,000
R21 · FY2016 · HD · contact PI
National Exposure Assessment Laboratory at Emory$785,026
U2C · FY2015 · ES · contact PI
STOPNASH Meeting$20,000
R13 · FY2015 · DK · contact PI
A Pilot Study of Losartan in the Treatment of Pediatric NAFLD$71,225
R03 · FY2014 · DK · contact PI
A Pilot Study of Losartan in the Treatment of Pediatric NAFLD$80,217
R03 · FY2013 · DK · contact PI
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease$173,394
K23 · FY2012 · DK · contact PI
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease$174,139
K23 · FY2011 · DK · contact PI
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease$174,139
K23 · FY2010 · DK · contact PI
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease$174,139
K23 · FY2009 · DK · contact PI
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease$1,080
K23 · FY2009 · DK · contact PI
Dietary Fructose and Redox Effects in Pediatric Nonalcoholic Fatty Liver Disease$174,139
K23 · FY2008 · DK · contact PI